D37.8 - Neoplasm of uncertain behavior of other specified digestive organs

Approximate Synonyms

The following clinical terms are approximate synonyms or lay terms that might be used to identify the correct diagnosis code:

• Carcinoid tumor of intestine
• Carcinoid tumor of pancreas
• Diffuse leiomyomatosis of esophagus
• Gastrinoma
• Gastrinoma of pancreas
• Glucagonoma syndrome
• Necrolytic migratory erythema
• Neoplasm of body of pancreas
• Neoplasm of cervical esophagus
• Neoplasm of head of pancreas
• Neoplasm of middle third of esophagus
• Neoplasm of muscle of perineum
• Neoplasm of tail of pancreas
• Neoplasm of thoracic esophagus
• Neoplasm of uncertain behavior of abdominal esophagus
• Neoplasm of uncertain behavior of anal canal
• Neoplasm of uncertain behavior of anal canal and sphincter
• Neoplasm of uncertain behavior of anus
• Neoplasm of uncertain behavior of body of pancreas
• Neoplasm of uncertain behavior of cervical esophagus
• Neoplasm of uncertain behavior of esophagus
• Neoplasm of uncertain behavior of head of pancreas
• Neoplasm of uncertain behavior of intestinal tract
• Neoplasm of uncertain behavior of islets of Langerhans
• Neoplasm of uncertain behavior of lower third of esophagus
• Neoplasm of uncertain behavior of middle third of esophagus
• Neoplasm of uncertain behavior of muscle of perineum
• Neoplasm of uncertain behavior of muscle of trunk
• Neoplasm of uncertain behavior of pancreas
• Neoplasm of uncertain behavior of pancreatic duct
• Neoplasm of uncertain behavior of spleen
• Neoplasm of uncertain behavior of tail of pancreas
• Neoplasm of uncertain behavior of thoracic esophagus
• Neoplasm of uncertain behavior of upper third of esophagus
• Neoplasm of upper third of esophagus
• Somatostatinoma

Clinical Information

• Necrolytic Migratory Erythema-. recurrent cutaneous manifestation of glucagonoma characterized by necrolytic polycyclic migratory lesions with scaling borders. it is associated with elevated secretion of glucagon by the tumor. other conditions with elevated serum glucagon levels such as hepatic cirrhosis may also result in similar skin lesions, which are referred to as pseudoglucagonoma syndrome.
• Somatostatinoma-. a somatostatin-secreting tumor derived from the pancreatic delta cells (somatostatin-secreting cells). it is also found in the intestine. somatostatinomas are associated with diabetes mellitus; cholelithiasis; steatorrhea; and hypochlorhydria. the majority of somatostatinomas have the potential for metastasis.
• Gastrinoma-. a gastrin-secreting neuroendocrine tumor of the non-beta islet cells, the gastrin-secreting cells. this type of tumor is primarily located in the pancreas or the duodenum. majority of gastrinomas are malignant. they metastasize to the liver; lymph nodes; and bone but rarely elsewhere. the presence of gastrinoma is one of three requirements to be met for identification of zollinger-ellison syndrome, which sometimes occurs in families with multiple endocrine neoplasia type 1; (men 1).

Diagnostic Related Groups - MS-DRG Mapping

The is diagnosis code is grouped in the following groups for version MS-DRG V40.0 What are Diagnostic Related Groups?
The Diagnostic Related Groups (DRGs) are a patient classification scheme which provides a means of relating the type of patients a hospital treats. The DRGs divides all possible principal diagnoses into mutually exclusive principal diagnosis areas referred to as Major Diagnostic Categories (MDC). applicable from 10/01/2022 through 09/30/2023.

Convert to ICD-9 Code

Table of Neoplasms

Patient Education

Digestive Diseases

When you eat, your body breaks food down to a form it can use to build and nourish cells and provide energy. This process is called digestion.

Your digestive system is a series of hollow organs joined in a long, twisting tube. It runs from your mouth to your anus and includes your esophagus, stomach, and small and large intestines. Your liver, gallbladder and pancreas are also involved. They produce juices to help digestion.

There are many types of digestive disorders. The symptoms vary widely depending on the problem. In general, you should see your doctor if you have:

• Blood in your stool
• Changes in bowel habits
• Severe abdominal pain
• Unintentional weight loss
• Heartburn not relieved by antacids

NIH: National Institute of Diabetes and Digestive and Kidney Diseases

Code History

• FY 2023 - No Change, effective from 10/1/2022 through 9/30/2023
• FY 2022 - No Change, effective from 10/1/2021 through 9/30/2022
• FY 2021 - No Change, effective from 10/1/2020 through 9/30/2021
• FY 2020 - No Change, effective from 10/1/2019 through 9/30/2020
• FY 2019 - No Change, effective from 10/1/2018 through 9/30/2019
• FY 2018 - No Change, effective from 10/1/2017 through 9/30/2018
• FY 2017 - No Change, effective from 10/1/2016 through 9/30/2017
• FY 2016 - New Code, effective from 10/1/2015 through 9/30/2016 (First year ICD-10-CM implemented into the HIPAA code set)